1. Zataria multiflora affects pulmonary function tests, respiratory symptoms, bronchodilator drugs use and hematological parameters in chronic obstructive pulmonary disease patients: A randomized doubled-blind clinical trial.
- Author
-
Ghorani, Vahideh, Rajabi, Omid, Mirsadraee, Majid, Amini, Mahnaz, Ghaffari, Shadi, and Boskabady, Mohammad Hossein
- Subjects
- *
PHYTOTHERAPY , *INFLAMMATION prevention , *RESPIRATORY disease prevention , *PULMONARY function tests , *LEUCOCYTES , *STATISTICAL sampling , *RESPIRATION , *HERBAL medicine , *NEUTROPHILS , *RESPIRATORY diseases , *TREATMENT effectiveness , *RANDOMIZED controlled trials , *PLANT extracts , *PARASYMPATHOLYTIC agents , *ANALGESICS , *PERSIAN medicine , *RESPIRATORY organ physiology , *DRUG efficacy , *FORCED expiratory volume , *OBSTRUCTIVE lung diseases , *COMPARATIVE studies , *ANTITUSSIVE agents , *BRONCHODILATOR agents , *EVALUATION - Abstract
Zataria multiflora is employed as an antitussive, anti-spasmodic, analgesic and etc. Agent in traditional medicine. The modern medical studies are also confirmed effects of this plant for treatment of respiratory problems via anti-inflammatory, anti-oxidant and immunomodulatory properties. We evaluated efficacy of Z. multiflora on tests of pulmonary function, respiratory symptoms, inhaled bronchodilator drugs use, and hematological factors in COPD patients. Patients (n = 45) were randomly grouped in the following three groups: placebo group (P), groups received Z. multiflora extract 3 and 6 mg/kg/day (Z3 and Z6). FEV 1 and MEF 25 - 75 , respiratory symptoms, inhaled bronchodilator drugs use and hematological factors were evaluated before and 1–2 months after treatment. Z. multiflora led to significant enhancement of FEV 1 (p < 0.05 to p < 0.01). Respiratory symptoms were also considerably ameliorated following treatment with extracts for 1 and 2 months compared to baseline values (p < 0.05 to p < 0.001). In groups received extract, inhaled bronchodilator drugs use was remarkably declined at the end of study (both, p < 0.05). Reduction of total WBC was observed 1–2 months after treatment in treated groups with extract compared to baseline values (p < 0.05 to p < 0.001). Neutrophils were remarkably declined in Z3 and Z6 groups after 2-monthes compared to 1-month treatment (p < 0.05 to p < 0.01). The evidence show therapeutic effect of this herb on COPD patients which could be result from properties that help to decrease inflammation. [Display omitted] • Zataria multiflora treatment leads to following changes in COPD patients: • Improvement of respiratory symptoms and CAT score. • Increase of FEV 1 value. • Reduction of inhaled bronchodilator drugs use. • Reduction of total WBC and neutrophil counts. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF